128 related articles for article (PubMed ID: 37968154)
1. Targeting GPX4-mediated Ferroptosis Alleviates Liver Steatosis in a Rat Model of Total Parenteral Nutrition.
Cheng S; Wang Y; Zhao Y; Wang N; Yan J; Jiang L; Cai W
J Pediatr Surg; 2024 May; 59(5):981-991. PubMed ID: 37968154
[TBL] [Abstract][Full Text] [Related]
2. Targeted metabolomics unravels altered phenylalanine levels in piglets receiving total parenteral nutrition.
Jiang L; Liu Y; Zhou Y; Xu Q; Cheng S; Yan J; Xiao Y; Han L; Wang Y; Cai W
FASEB J; 2023 Jul; 37(7):e23014. PubMed ID: 37261736
[TBL] [Abstract][Full Text] [Related]
3. Ω-3 fatty acids prevent hepatic steatosis, independent of PPAR-α activity, in a murine model of parenteral nutrition-associated liver disease.
Prince E; Lazare FB; Treem WR; Xu J; Iqbal J; Pan X; Josekutty J; Walsh M; Anderson V; Hussain MM; Schwarz SM
JPEN J Parenter Enteral Nutr; 2014 Jul; 38(5):608-16. PubMed ID: 23757305
[TBL] [Abstract][Full Text] [Related]
4. Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease.
Koelfat KVK; Schaap FG; Hodin CMJM; Visschers RGJ; Svavarsson BI; Lenicek M; Shiri-Sverdlov R; Lenaerts K; Olde Damink SWM
Clin Nutr; 2017 Oct; 36(5):1403-1410. PubMed ID: 28029505
[TBL] [Abstract][Full Text] [Related]
5. Alteration of canalicular transporters in a mouse model of total parenteral nutrition.
Tazuke Y; Teitelbaum DH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):193-202. PubMed ID: 19179882
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of hepatic steatosis during total parenteral nutrition.
Nussbaum MS; Fischer JE
Surg Annu; 1991; 23 Pt 2():1-11. PubMed ID: 1907028
[TBL] [Abstract][Full Text] [Related]
7. Cysteine supplementation and reduction of total parenteral nutrition-induced hepatic lipid accumulation in the weanling rat.
Narkewicz MR; Caldwell S; Jones G
J Pediatr Gastroenterol Nutr; 1995 Jul; 21(1):18-24. PubMed ID: 8576809
[TBL] [Abstract][Full Text] [Related]
8. Liver Disease in Patients on Total Parenteral Nutrition.
Mitra A; Ahn J
Clin Liver Dis; 2017 Nov; 21(4):687-695. PubMed ID: 28987256
[TBL] [Abstract][Full Text] [Related]
9.
Xu J; Zhou Y; Cheng S; Zhao Y; Yan J; Wang Y; Cai W; Jiang L
Metabolites; 2023 Sep; 13(10):. PubMed ID: 37887368
[TBL] [Abstract][Full Text] [Related]
10. The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model.
Matsukubo M; Yano K; Kaji T; Sugita K; Onishi S; Harumatsu T; Nagano A; Matsui M; Murakami M; Yamada K; Yamada W; Muto M; Kumagai K; Ido A; Ieiri S
Pediatr Surg Int; 2021 Mar; 37(3):353-361. PubMed ID: 33388954
[TBL] [Abstract][Full Text] [Related]
11. Total parenteral nutrition induces liver steatosis and apoptosis in neonatal piglets.
Wang H; Khaoustov VI; Krishnan B; Cai W; Stoll B; Burrin DG; Yoffe B
J Nutr; 2006 Oct; 136(10):2547-52. PubMed ID: 16988124
[TBL] [Abstract][Full Text] [Related]
12. Reversal of hepatic steatosis in rats by addition of glucagon to total parenteral nutrition (TPN).
Li SJ; Nussbaum MS; McFadden DW; Dayal R; Fischer JE
J Surg Res; 1989 Jun; 46(6):557-66. PubMed ID: 2499733
[TBL] [Abstract][Full Text] [Related]
13. Exogenous Secretin Improves Parenteral Nutrition-associated Liver Disease in Rats.
Cao X; Feng F; Liu X; Sun C; Yang X; Fang Y; Li S
J Pediatr Gastroenterol Nutr; 2020 Apr; 70(4):430-435. PubMed ID: 32022775
[TBL] [Abstract][Full Text] [Related]
14. Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat.
Pappo I; Bercovier H; Berry E; Gallilly R; Feigin E; Freund HR
JPEN J Parenter Enteral Nutr; 1995; 19(1):80-2. PubMed ID: 7658606
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of hepatic steatosis in the parenterally fed rat.
Hall RI; Grant JP; Ross LH; Coleman RA; Bozovic MG; Quarfordt SH
J Clin Invest; 1984 Nov; 74(5):1658-68. PubMed ID: 6438155
[TBL] [Abstract][Full Text] [Related]
16. Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in rats.
Li SJ; Nussbaum MS; McFadden DW; Zhang FS; LaFrance RJ; Dayal R; Fischer JE
J Surg Res; 1990 May; 48(5):421-6. PubMed ID: 2112667
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline and thalidomide fail to reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat.
Vromen A; Spira RM; Bercovier H; Berry E; Freund HR
JPEN J Parenter Enteral Nutr; 1997; 21(4):233-4. PubMed ID: 9252951
[TBL] [Abstract][Full Text] [Related]
18. Alterations of gut microbiota and serum bile acids are associated with parenteral nutrition-associated liver disease.
Wang N; Wang J; Zhang T; Huang L; Yan W; Lu L; Jia J; Tao Y; Cai W; Wang Y
J Pediatr Surg; 2021 Apr; 56(4):738-744. PubMed ID: 32732165
[TBL] [Abstract][Full Text] [Related]
19. Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats.
Li SJ; Nussbaum MS; McFadden DW; Gapen CL; Dayal R; Fischer JE
Surgery; 1988 Aug; 104(2):350-7. PubMed ID: 3135627
[TBL] [Abstract][Full Text] [Related]
20. Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1/miR-214-3p/GPX4.
He GN; Bao NR; Wang S; Xi M; Zhang TH; Chen FS
Drug Des Devel Ther; 2021; 15():3965-3978. PubMed ID: 34566408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
